Chief Executive Officer

Publication date: 6 July 2017

Chief executive officer for the Alsace Regional Cancer Institute and Comprehensive Cancer Center Paul Strauss.

Job description

With respect to the Public Health regulations, «[…..] the Chief Executive is appointed for a 5 year term potentially renewable one time by the Ministry of Health after the recommendations of the Advisory Board and the National Federation, the highest representative boards of Cancer Centers» (article L.6162-10).
The Chief Executive officer is in charge of global policy and ensures reporting to the Advisory board and regional health authorities. He/she represents the Center in court of law and in all civil actions. In addition, he/she will be the administrator of the Regional Cancer Institute GCS opening in June 2018. 

Candidate profile

  • Academic physician with outstanding expertise in oncology and/or hematology fields;
  • Excellent experience in management and partnership development between academic and private institutions;
  • Outstanding human capacities and international leadership recognition;
  • Excellent skills in organization of oncology care ;
  • Strong experience in preclinical and clinical research at national and international levels;
  • Experience of cooperation with academic and industrial partnerships at the international level;
  • Excellent skills in fluent and scientific French and English languages are mandatory. German language skills will be considered as an advantage.

The Alsace Regional Cancer Institute (IRC)

IRC is a new infrastructure entirely dedicated to the diagnosis and treatment of cancer patients in a dedicated new building. The goal of the IRC project is the development of clinical expertise and research at an international level for the benefit of patients and society. The Strasbourg University scientific environment combined with the different academic and industrial partnerships represent a genuine opportunity to be at the forefront of precision medicine to cure cancer patients. The IRC will open its doors in June 2018.

Staff: 700 employees including over 120 physicians and pharmacists and 165 nurses.

Capacity and equipment: The IRC will occupy an area of 30,000 m² and will be fully equipped. It will group together in a single building several departments: medical oncology, hematology (with a bone marrow transplant unit), supportive care, radiotherapy, nuclear medicine, surgery (for breast cancers, gynecological and thyroid pathologies) with an anesthesia team and an intensive care unit. IRC will have a clinical research department with an early Phase unit linked to a laboratory of oncobiology and a bio bank. IRC is a member of the major cooperative research groups (Unicancer, FHF Cancer, EORTC, SAKK,GYNECO…)
The IRC will offer 161 beds and 71 day-hospital beds. The technical platform for radiotherapy will include 6 accelerators including 3 Tomotherapy machines as well as radiotherapy techniques under stereotactic conditions and a brachytherapy unit. The Department of Nuclear Medicine will have 2 PetScan (with a short-term project for a Pet MRI), 4 gamma cameras, 2 coupled to a scanner and a 7-bed protected units for metabolic radiotherapy.
The IRC is physically linked to another new 40,000-m² medical medico-technical center which will open in March 2018. It will include an imaging department (5 MRIs and 3 scanners) as well as operating theaters for other surgical services installed on the site and a day surgery unit for 30 patients. This building will also house teaching space. 
The IRC is also directly linked to the University Hospital of Hautepierre, with the main surgical departments involved in cancer-related activities (Digestive and Hepato-Biliary Surgery, Neurosurgery, ENT, Gynecology and Senology, Orthopedics, Plastic Surgery and Reconstruction). There is also on the site the onco-pediatric department.

Partnerships: IRC is associated with the University of Strasbourg and the prestigious research institutions of the Strasbourg site: Institute of Genetics and Molecular and Cellular Biology, Engineering School for Biotechnology, Institute of Molecular and Cellular Biology, Institute of Science and Supramolecular Engineering, School of Chemistry, Hubert Curien Pluridisciplinary Institute (CNRS Unit dedicated to biophysics and radiobiology). An INSERM Unit is on the site (IRFAC Interface Laboratory for Fundamental and Applied Cancer Research).

Management: Aphysician oncologist or hematologist will lead the IRC. The IRC director defines the Institute's medical, scientific and human resources policies. The director is in charge of the budget and investment decisions and is asssted by an appointed management team.

Legal structure: IRC is governed by the Private Healthcare Cooperation Group (GCS) associating the Comprehensive Cancer Center Paul Strauss and the University Hospitals of Strasbourg. IRC is a university hospital.

Estimated yearly running budget: 105 MEuros.

Institution

Alsace Regional Cancer Institute and Comprehensive Cancer Center Paul Strauss

3 rue de la Porte de l'Hôpital
67065 Strasbourg Cedex
France

How to apply

Complete applications must contain in the following order; motivation letter (two pages max.), CV, titles proofs, and diplomas copies. A single file has to be electronically submitted to  sdirection@strasbourg.unicancer.fr as well as a hard copy to :
Monsieur le Président du Conseil d’Administration
Centre Paul STRAUSS
3, Rue de la Porte de l’Hôpital – BP 30042
67065 STRASBOURG Cedex. Bas-Rhin, France

Application deadline

Application submission deadline is Wednesday, August 16, 2017, at 6.00 pm, French time, at the latest. The successful candidate will be expetced to begin in November 2017 at the latest.

ESMO Disclaimer

It is the Advertisers' responsibility to ensure that any material submitted for inclusion on this section of the ESMO website complies with all relevant laws and regulations (including the Data Protection Act 1998). Individuals applying for the position above should make direct contact with the institution making the offer and are responsible to verify the validity of the offer. The European Society for Medical Oncology will not accept responsibility for any error, omission or inaccuracy in any job advertising materials on this section of the website.

Submissions from individuals seeking jobs/positions will not be accepted.

Job openings at the European Society for Medical Oncology’s headquarters are not posted on this website. For enquiries about opportunities at ESMO or to spontaneously submit your CV, you may contact the ESMO Head Office.